Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06380686 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome

Study acronym: HEAT
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of May 2024 to Nov 7, 2024 · Study sites: 1 to 2 · Primary completion date: May 2029 to Nov 2029 · 2 morev2 Show 5 more changesShow less
    • Start date changed from estimate of May 2024 to Nov 7, 2024
    • Study sites: 1 to 2
    • Primary completion date: May 2029 to Nov 2029
    • Completion date: May 2030 to Nov 2030
    • Eligibility criteria shortened, about 54 words

    See this version in full on ClinicalTrials.gov ↗

  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Prospective, open, non-interventional, multi-center clinical registry study with the aim to establish a comprehensive research platform reflecting the real-world treatment landscape for recurrent/metastatic head and neck tumor patients.
Trial Details
NCT Number NCT06380686
Lead Sponsor AIO-Studien-gGmbH
Collaborators: Merck Sharp & Dohme LLC
Conditions Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Oropharynx, Squamous Cell Carcinoma of the Hypopharynx, Squamous Cell Carcinoma of the Larynx
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov